Generated automatically from the NAFDAC register, WHO alerts and community data as of today. Not medical advice — always follow your doctor or pharmacist.
From the official U.S. FDA label for varicella-zoster vaccine, the active ingredient registered with NAFDAC.
Temporarily relieves symptoms of runny nose, fever & cough.**
Temporarily relieves symptoms of runny nose, fever & cough.**
IF PREGNANT OR BREAST-FEEDING , ask a health care professional before use. KEEP OUT OF THE REACH OF CHILDREN. In case of overdose (or accidental ingestion) get medical help or contact a Poison Control Center right away. Do not use if TAMPER EVIDENT seal is broken or missing.
Add the expiry date printed on your pack for a full Trust Score — or look up uses, side effects and cheaper generics.
Varilrix Vaccine contains Varicella-zoster vaccine, Live attenuated (0.5 mL), as powder for injection, according to its NAFDAC registration record.
Yes. Varilrix Vaccine is listed on the NAFDAC register under registration number A6-0191, and its registration is active as of 5 November 2026.
No WHO falsified or substandard medical product alert currently matches Varilrix Vaccine in our automatically synced alert list.
Run a free authenticity scan with the NAFDAC number A6-0191, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.
Temporarily relieves symptoms of runny nose, fever & cough.** (Summarised from the official U.S. FDA label for varicella-zoster vaccine. Always follow your doctor or pharmacist.)
Reviews are personal experiences from RxVerify users, not medical advice. Report side effects to your doctor and to NAFDAC.